eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc.verified




Market Cap:


eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is head...[Read more]



IPO Date


Stock Exchange




The PE Ratio as of May 2024 (TTM) for eFFECTOR Therapeutics, Inc. (EFTR) is -0.12

According to eFFECTOR Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.12. This represents a change of -90.34% compared to the average of -1.24 of the last 4 quarters.

eFFECTOR Therapeutics, Inc. (EFTR) Historical PE Ratio (quarterly & annually)

How has EFTR PE Ratio performed in the past?

The mean historical PE Ratio of eFFECTOR Therapeutics, Inc. over the last ten years is 4.99. The current -0.12 PE Ratio has changed -340.49% with respect to the historical average. Over the past ten years (40 quarters), EFTR's PE Ratio was at its highest in in the September 2021 quarter at 15.97. The PE Ratio was at its lowest in in the December 2020 quarter at -93.76.

Quarterly (TTM)









eFFECTOR Therapeutics, Inc. (EFTR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of eFFECTOR Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 102.05%

Maximum Annual PE Ratio = 21.17

Minimum Annual Increase = -326.74%

Minimum Annual PE Ratio = -4.62

Quarterly (TTM)
YearPE RatioChange

eFFECTOR Therapeutics, Inc. (EFTR) Average PE Ratio

How has EFTR PE Ratio performed in the past?

The current PE Ratio of eFFECTOR Therapeutics, Inc. (EFTR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg


5-year avg


10-year avg


eFFECTOR Therapeutics, Inc. (EFTR) PE Ratio vs. Peers

How is EFTR’s PE Ratio compared to its peers?

eFFECTOR Therapeutics, Inc.’s PE Ratio is greater than Indaptus Therapeutics, Inc. (-1.30), greater than Jasper Therapeutics, Inc. (-4.80), greater than RenovoRx, Inc. (-2.54), greater than Ensysce Biosciences, Inc. (-0.31), less than Virpax Pharmaceuticals, Inc. (-0.05),

Build a custom stock screener for eFFECTOR Therapeutics, Inc. (EFTR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like eFFECTOR Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

eFFECTOR Therapeutics, Inc. (EFTR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like eFFECTOR Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is eFFECTOR Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for eFFECTOR Therapeutics, Inc. (EFTR)?

What is the highest PE Ratio for eFFECTOR Therapeutics, Inc. (EFTR)?

What is the 3-year average PE Ratio for eFFECTOR Therapeutics, Inc. (EFTR)?

What is the 5-year average PE Ratio for eFFECTOR Therapeutics, Inc. (EFTR)?

How does the current PE Ratio for eFFECTOR Therapeutics, Inc. (EFTR) compare to its historical average?